Skip to main content
. 2017 Jan 16;6(1):79–87. doi: 10.1016/j.imr.2017.01.004

Fig. 4.

Fig. 4

(A) Morphological changes showing inhibition of DU-145 prostate cancer cell lines, whereas no inhibition was observed on MEF-L929 normal cell line for 72 hours. (B) Morphological changes showing inhibition of PC-3 prostate cancer cell lines, whereas no inhibition was observed on MEF-L929 normal cell line for 72 hours. (C) Morphological changes of standard drug paclitaxel on DU-145 and PC-3 prostate cancer cell lines.

BL, membrane blebbing (magnification for DU-145 was 20 × and PC-3 was 40 × ); CS Created by potrace 1.16, written by Peter Selinger 2001-2019 Cellular shrinkage.